HIV and cervical cancer in Kenya

Show simple item record

dc.contributor.author Gichangi, P.
dc.contributor.author Vuyst, H. De
dc.contributor.author Estambale, Benson B.
dc.contributor.author Rogo, K.
dc.contributor.author Bwayo, J.
dc.contributor.author Temmerman, M.
dc.date.accessioned 2018-06-25T13:07:29Z
dc.date.available 2018-06-25T13:07:29Z
dc.date.issued 2002-01-22
dc.identifier.uri https://obgyn.onlinelibrary.wiley.com/doi/full/10.1016/S0020-7292%2801%2900560-4#
dc.identifier.uri https://doi.org/10.1016/S0020-7292(01)00560-4
dc.identifier.uri http://ir.jooust.ac.ke:8080/xmlui/handle/123456789/1326
dc.description https://doi.org/10.1016/S0020-7292(01)00560-4 en_US
dc.description.abstract To determine the effect of the HIV epidemic on invasive cervical cancer in Kenya. Methods: Of the 3902 women who were diagnosed with reproductive tract malignancies at Kenyatta National Hospital (KNH) from 1989 to 1998, 85% had invasive cervical cancer. Age at presentation and severity of cervical cancer were studied for a 9‐year period when national HIV prevalence went from 5% to 5–10%, to 10–15%. Results:There was no significant change in either age at presentation or severity of cervical cancer. Of the 118 (5%) women who were tested for HIV, 36 (31%) were seropositive. These women were 5 years younger at presentation than HIV‐negative women. Conclusions: A two‐ to three‐fold increase in HIV prevalence in Kenya did not seem to have a proportional effect on the incidence of cervical cancer. Yet, HIV‐positive women who presented with cervical cancer were significantly younger than HIV‐negative women. en_US
dc.language.iso en en_US
dc.publisher International Journal of Gynecology & Obstetrics en_US
dc.subject HIV en_US
dc.subject Cervical cancer en_US
dc.subject Kenya en_US
dc.title HIV and cervical cancer in Kenya en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account